A XM não fornece serviços a residentes nos Estados Unidos da América.

Wall Street jumps after cooling inflation data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Wall Street jumps after cooling inflation data</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

Traders add to Fed rate cut bets as inflation eases

Nike slumps after results

Infinera rises after Nokia to buy company

Indexes: Dow 0.34%, S&P 0.30%, Nasdaq 0.24%

Updated at 9:43 a.m. ET/1343 GMT

By Ankika Biswas and Lisa Pauline Mattackal

June 28 (Reuters) - U.S. stocks rose broadly on Friday after an in-line inflation report strengthened hopes for interest rate cuts in September, though Nike shares slumped after a dismal annual sales forecast.

The Commerce Department's data showed personal consumption expenditures (PCE) price index - the Fed's preferred inflation gauge - was unchanged on a monthly basis in May and rose 2.6% annually, all along expectations.

Excluding the volatile food and energy components, the core figure increased 0.1% month-on-month and 2.6% annually.

Chances of a rate cut in September inched up to 68% from 61% before the data, as per LSEG FedWatch data.

"This is a perfect report - it gives the Fed the green light to cut in September, and sets the stage for the dovish rhetoric to continue," said Jay Woods, chief global strategist at Freedom Capital Markets.

Traders held their bets of two cuts despite Fed projections of just one this year, hopingfor a sustained downtrend in inflation and as the economy remains susceptible to decades-high interest rate.

Megacaps including Apple<AAPL.O>, Nvidia NVDA.O, andAmazon.com AMZN.O rose between 0.2% and 1.2%.

Most of the S&P 500 subsectors were higher, led bytech stocks .SPLRCT. The small-cap Russell 2000 .RUT rose0.8% to an over two week-high.

However, Nike NKE.N slumped 17.1% after forecasting a surprise drop in fiscal 2025 revenue, weighing on the broader consumer discretionary sector .SPLRCD.

At 9:43 a.m. ET, the Dow Jones Industrial Average .DJI was up 133.28 points, or 0.34%, at 39,297.34, the S&P 500 .SPX was up 16.64 points, or 0.30%, at 5,499.51, and the Nasdaq Composite .IXIC was up 42.09 points, or 0.24%, at 17,900.77.

Richmond Fed President Thomas Barkin said he still wanted to proceed "deliberately" on policy and the Fed's Mary Daly said the latest data was "good news that policy is working."

Comments from Fed official Michelle Bowman is also expected during the day.

Investors also geared up for the final reconstitution of the Russell benchmark indexes during the day, with the furious rally in AI-related stocks expected to leave an outsized imprint on their final shape.

Both the S&P 500 and the Nasdaq were set for gains in a week marked by a short-lived rout in AI-related stocks, Amazon.com hitting $2 trillion market value for the first time, quarterly earnings from the likes of FedEx FDX.N and Micron Technology MU.O, and a mixed bag of economic data.

The two indexes were set for quarterly gains. However the blue-chip Dow .DJI was on pace to end the quarter down 1%, highlighting the divergence between the more tech-heavy indexes and the rest of the market.

Trump Media & Technology Group DJT.O gained 4% after ashaky performance from Democratic incumbent Joe Biden in thefirst presidential debate.

Optical networking gear maker Infinera INFN.O jumped 18.4% after Nokia NOKIA.HE said it would acquire the company in a $2.3 billion deal.

Advancing issues outnumbered decliners by a 4.16-to-1 ratio on the NYSE. Advancing issues outnumbered decliners by a 2.18-to-1 ratio on the Nasdaq.

The S&P index recorded 12 new 52-week highs and one new low, while the Nasdaq recorded 35 new highs and 38 new lows.


Nasdaq leads Wall Street's 2024 rally https://tmsnrt.rs/3XChlUe


Reporting by Ankika Biswas and Lisa Mattackal in Bengaluru; Editing by Maju Samuel

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.